Reminder: ChromaDex management will host an investor conference call today at 4:30 p.m. ET to discuss second quarter 2024 financial results and provide a general business update. For details: https://bit.ly/3Yi3qmK
ChromaDex
Wellness and Fitness Services
Los Angeles, California 8,880 followers
ChromaDex (NASDAQ: $CDXC) is the global authority on NAD+, focusing on the science of healthy aging.
About us
ChromaDex Corp. (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. The ChromaDex team, comprised of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to other everyday stressors. NAD+ depletion is a contributor to age-related changes in health and vitality. Setting the benchmark as the gold standard in scientific rigor, safety, quality, and transparency, ChromaDex is the innovator behind its clinically proven flagship ingredient, NIAGEN® (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available. NIAGEN NR is the active ingredient in ChromaDex’s consumer products, sold as the brand Tru Niagen®, the number one healthy-aging NAD+ supplement in the United States*. Clinically proven to increase NAD+ levels, Tru Niagen is helping people around the world transform the way they age (available at www.truniagen.com). ChromaDex’s robust patent portfolio protects NR and other NAD+ precursors. ChromaDex maintains a website at www.chromadex.com, to which ChromaDex regularly publishes copies of its press releases, news, and financial information. *Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 3/1/2023-2/29/2024).
- Website
-
http://www.chromadex.com
External link for ChromaDex
- Industry
- Wellness and Fitness Services
- Company size
- 51-200 employees
- Headquarters
- Los Angeles, California
- Type
- Public Company
- Founded
- 1999
- Specialties
- Ingredient technologies, Reference Standards, Product regulatory and safety consulting, and Consumer Products
Locations
-
Primary
Get directions
10900 Wilshire Blvd
Suite 600
Los Angeles, California 92618, US
-
Get directions
1735 Flight Way
Suite 200
Tustin, CA 92782, US
-
Get directions
1751 S Fordham St
350
Longmont, Colorado 80503, US
Employees at ChromaDex
-
Matt Petersen
CEO & Board Member, VC / PE Companies | Technology, Beauty, F&B, CPG, Entertainment | Product Launches, Brand Marketing, Exit Strategy
-
Jason Brody
Helping people, brands, companies define their identities and create content that connects deeply with their audiences
-
David Kroes
HR Leader @ ChromaDex | Driving Culture, Workplace Evolution, Talent Acquisition, Organizational Development
-
Albert Rembert
VP Quality and Product Safety at ChromaDex
Updates
-
ChromaDex announced that its Chief Executive Officer, Rob Fried, and Interim Chief Financial Officer, James Lee, will participate at Canaccord Genuity - Global Capital Markets 44th Annual Growth Conference, taking place from August 13 to 15, 2024, at the InterContinental in Boston. Find details: https://bit.ly/4cjeBPc #GCDriven #DrivenByYourSuccess
-
ChromaDex's flagship product, Tru Niagen® has been recognized as the best overall NR (#NicotinamideRiboside) supplement for #longevity on the market by Healthnews! Find out more: https://bit.ly/3S66C0L #Niagen #TruNiagen #NAD #NR #cellularhealth #healthyaging
-
A recent study published in Nature Communications showcased the promising functional mobility benefits of nicotinamide riboside (NR) supplementation for people with peripheral artery disease (PAD). Read more in the Daily Mail: https://bit.ly/3LM9g8t #Niagen #NAD #NR #PAD #peripheralarterydisease
-
With the recent launch of the Niagen+ NAD+ Test Kit, ChromaDex continues to advance NAD+ research and provide HCPs with innovative solutions for healthy aging. https://bit.ly/4dct54f #Niagen #NAD #healthyaging
-
ChromaDex is honored to be a platinum sponsor at this year's FASEB NAD+ Metabolism and Signaling Conference, scheduled for August 25 - 29 in Lisbon, Portugal. For event details and registration, please visit: https://bit.ly/46htXSX #NADSRC #NAD
-
-
Setting a new standard in analytical NAD+ measurement methods, ChromaDex's Niagen+ NAD+ Test Kit features cutting-edge dried blood spot (DBS) assay technology, ensuring the stability of NAD+ samples during transport for precise and validated results. https://bit.ly/4dct54f #Niagen #NAD
-
ChromaDex will hold a conference call on Wednesday, August 7, 2024 at 4:30 p.m. ET. to discuss its financial results for the second quarter, which ended June 30, 2024. For dial-in and webcast details: https://bit.ly/3Yi3qmK
-
Rob Fried, CEO of ChromaDex, highlights the company's launch of its Niagen+ NAD+ Test Kit, now available exclusively through the company’s healthcare practitioner (HCP) channel. Read more: https://bit.ly/4dct54f #Niagen #NAD
-
ChromaDex launched the Niagen+ NAD+ Test Kit, now available exclusively through the company’s healthcare practitioner (HCP) channel. This innovative test kit provides practitioners with a reliable method for measuring patient blood NAD+ levels, helping them create more personalized and effective patient protocols using ChromaDex’s NAD+-boosting HCP products, Tru Niagen® and Niagen+. Find details: https://bit.ly/4dct54f